Iovance Biotherapeutics

Iovance Biotherapeutics (NASDAQ: IOVA) stock spiked on Wednesday after receiving multiple price target upgrades post-FDA accelerated approval. Iovance Biotherapeutics (IOVA) […]

Iovance Biotherapeutics (NASDAQ: IOVA) stock jumped after the FDA granted accelerated approval for Amtagvi (lefileucel) as a treatment for advanced